{
    "clinical_study": {
        "@rank": "21738", 
        "arm_group": [
            {
                "arm_group_label": "Transarterial Supraselective Embolization", 
                "arm_group_type": "Experimental", 
                "description": "Transarterial supraselective embolization of prostatic arteria with Bead Block 300-500 \u03bcm"
            }, 
            {
                "arm_group_label": "Transurethral Resection", 
                "arm_group_type": "Active Comparator", 
                "description": "Surgery to remove part of the prostate gland"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether the transarterial supraselective\n      embolization (TSE) is a technique as effective as transurethral resection of the prostate\n      (TURP) for the treatment of lower urinary tract symptoms associated with benign prostatic\n      hyperplasia (BPH)."
        }, 
        "brief_title": "Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Transurethral Resection of Prostate", 
            "Artery Embolization", 
            "Benign Prostatic Hyperplasia", 
            "Lower Urinary Tract Symptoms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Prostatic Hyperplasia", 
                "Hyperplasia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of benign prostatic hyperplasia with moderate or severe obstructive lower\n             urinary tract symptoms\n\n          -  Refractory to medical treatment for at least 6 months\n\n          -  Qmax (maximum urinary flow) less than 10 mL/second\n\n        Exclusion Criteria:\n\n          -  Advanced atherosclerosis and tortuosity of the iliac arteries\n\n          -  No visualization of the prostatic artery CT angiography study\n\n          -  Urethral stenosis, detrusor failure or neurogenic bladder\n\n          -  Glomerular filtration < 30 mL/min\n\n          -  Presence of malignant tumor\n\n          -  History of allergy to iodinated contrast"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963312", 
            "org_study_id": "FMSECUR-11", 
            "secondary_id": "2011-002108-34"
        }, 
        "intervention": [
            {
                "arm_group_label": "Transarterial Supraselective Embolization", 
                "intervention_name": "Transarterial Supraselective Embolization of the prostate", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Transurethral Resection", 
                "intervention_name": "Transurethral Resection of the prostate", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 11, 2014", 
        "link": {
            "url": "http://www.navarrabiomed.es"
        }, 
        "location": {
            "contact": {
                "email": "fcapdevb@navarra.es", 
                "last_name": "Ferran Capdevila, PharmD", 
                "phone": "+34 848422163"
            }, 
            "facility": {
                "address": {
                    "city": "Pamplona", 
                    "country": "Spain", 
                    "state": "Navarre", 
                    "zip": "31008"
                }, 
                "name": "Complejo Hospitalario de Navarra"
            }, 
            "investigator": [
                {
                    "last_name": "Saturnino Napal, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Fermin Urtasun, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "I\u00f1igo Insausti, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised Clinical Trial to Compare Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate Compared Versus the Transurethral Resection of the Prostate to Treat the Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.", 
        "overall_contact": {
            "email": "saturnino.napal.lecumberri@cfnavarra.es", 
            "last_name": "Saturnino Napal, MD", 
            "phone": "+34 848422385"
        }, 
        "overall_official": {
            "affiliation": "Complejo Hospitalario de Navarra", 
            "last_name": "Saturnino Napal, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Maximum urinary flow (Qmax) measured prior intervention and one year later", 
            "measure": "Maximum urinary flow (Qmax)", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "reference": [
            {
                "PMID": "10877424", 
                "citation": "DeMeritt JS, Elmasri FF, Esposito MP, Rosenberg GS. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000 Jun;11(6):767-70."
            }, 
            {
                "PMID": "19908092", 
                "citation": "Carnevale FC, Antunes AA, da Motta Leal Filho JM, de Oliveira Cerri LM, Baroni RH, Marcelino AS, Freire GC, Moreira AM, Srougi M, Cerri GG. Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol. 2010 Apr;33(2):355-61. doi: 10.1007/s00270-009-9727-z. Epub 2009 Nov 12."
            }, 
            {
                "PMID": "23204546", 
                "citation": "Pisco J, Campos Pinheiro L, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, Vaz Santos V, Oliveira AG. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013 Feb;266(2):668-77. doi: 10.1148/radiol.12111601. Epub 2012 Nov 30."
            }, 
            {
                "PMID": "18309010", 
                "citation": "Mauro MA. Can hyperplastic prostate follow uterine fibroids and be managed with transcatheter arterial embolization? Radiology. 2008 Mar;246(3):657-8. doi: 10.1148/radiol.2463071721."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963312"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "International Prostate Symptom Score (IPSS) measured before and after the intervention", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Reduction in prostate volume", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Assessed by International Index of Erectile Function (IIEF) prior and and one year after intervention.", 
                "measure": "Sexual function", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Fundacion Miguel Servet", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundacion Miguel Servet", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}